PS1
PS1 has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 19, 2023: “Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in β-cell pathogenesis and diabetes in db/db mice”.
- 1 lab in 1 country
- Funders: Academia Sinica and 3 more
- Animals1
What did studies of PS1 find?
4Studies of PS1 measured 4 outcomes; the most studied are oxidative stress and ROS signaling (1 study), cell death (1) and longevity (1).
Oxidative stress and ROS signaling
downin mouse cells1
1 study
Oxidative stress and ROS signaling
downin mouse cells1
PS1 decreases oxidative stress and ROS signaling in mouse cells.
“This increase could be attributed to a reduction in ROS production and the activity of electron transport chain complex 1 (ETC C1) and Nox in Min6 cells by PS1.”
Cellshigh glucosepancreatic beta cells
Cellular and molecular life sciences : CMLS
Cell death
downin mice1
1 study
Cell death
downin mice1
PS1 decreases cell death in mice.
“Accordingly, PS1 reduced cell death and dysfunction in the pancreatic β-islets of db/db mice”
Animalsdb/db micepancreatic isletsn = 7
Cellular and molecular life sciences : CMLS
Longevity
upin mice1
1 study
Longevity
upin mice1
PS1 extends lifespan longevity in mice.
“reversed diabetes in db/db mice, 6 to 7 mice per group, as evidenced by blood glucose, glycosylated hemoglobin A1c (HbA1c), glucose tolerance test, diabetic incidence, survival and longevity (P < 0.05 or less).”
Animalsdb/db micen = 7
Cellular and molecular life sciences : CMLS
Diabetes
downin mice1
1 study
Diabetes
downin mice1
PS1 protects against diabetes in mice.
“Furthermore, PS1 alone and in combination with metformin significantly reversed diabetes in db/db mice”
Animalsdb/db micen = 7
Cellular and molecular life sciences : CMLS
Funding
2 grants since 2018National Institute on AgingUS$3.7m